Whitepaper

ASCO Reveals: Increasing Options For Relapse/ Refractory Patients In Haematological Malignancies
Hope for patients living with haematological malignancies; Immunotherapies represent a novel class of biologics
ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies

More Whitepapers / Newsletters

Herpes Zoster Oticus
Herpes Zoster Oticus

Herpes zoster oticus (HZ oticus) is a viral infection of the inner, middle, and external ear. A result of reactivation of varicella-zoster virus infection, it manifests as severe otalgia and associate...

Crohn's disease Newsletter
Crohn's disease

Crohn's disease (CD) is a type of inflammatory bowel disease (IBD). In this condition, the immune system mistakenly attacks healthy bacteria in the GI tract. Crohn's disease is more frequent in women...

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide, Rare disease pose a huge burden on the global healthcare system, affecting the qua...

Exocrine Pancreatic Insufficiency
Exocrine Pancreatic Insufficie...

A degenerative disease, Exocrine Pancreatic Insufficiency (EPI), is a consequence of insufficient production and secretion of pancreatic digestive enzymes, which leads to maldigestion in the duodenum....

Paroxysmal Nocturnal Hemoglobinuria Newsletter
Paroxysmal Nocturnal Hemoglobi...

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired disease that leads to the destruction of red blood cells, blood clots, and an impaired bone marrow caused due to the mutation in the PIGA (...